In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
PML and Disability
Tweet Progressive Multifocal Leukoencphalopathy is a nightmare associated with immunosuppressive treatment of MS and is most common with the migration inhibitors. PML is caused by JC virus with is common and affects most of us. If we are not immunosuppressed we deal with and kill the virus but if your immune system is compromised it…
Multiple Sclerosis is a F…ing Thief
How do you know? The Northeast Blizzard of 2026 brought blankets, hunkering down, power outtages and spotty internet. What it didn’t bring was new, creative ideas for an MS humor blog. To be fair, I wasn’t really having a ton of ideas before the blizzard hit but that remains irrelevant. So, on the last day…
CD44 a promising Target, MD ahead of his time?
Tweet Aljasir MA. An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis. Pharmaceuticals. 2026;19:254. Background: Multiple sclerosis (MS) is a neuroinflammatory disease characterized by autoimmune-driven inflammation in the central nervous system that damages axons and destroys myelin. It is difficult to diagnose multiple sclerosis due to its…
Placebo and Glatiramer Acetate Depot
Tweet Glatiramer acetate is the active ingredient in a drug that was originally sold as Trade Name Copaxone, which was invented in Israel in the 1970s as a random mix of 4 amino acids. This was given as a 20mg injection daily. As the patent protection expired they gave 40mg three times a week. It…
Ironically, cutting out coffee gave me a boost of energy
I wasn’t addicted to coffee. But my body was. As someone living well with multiple sclerosis, how I fuel my body matters to me — more than I sometimes realize. I didn’t fully appreciate how caffeine was affecting me until, by chance, I skipped it for two days. That first morning, I made a giant…
MS Awareness Month events highlight advocacy, education, fundraising
This March, organizations and advocates are marking Multiple Sclerosis Awareness Month with fundraisers, educational events, and other activities to spotlight the disease and its impact on an estimated 1.8 million people worldwide. The annual campaign reaches beyond the general public to include researchers, lawmakers, industry leaders, policymakers, and healthcare professionals. Its goal is to expand…
Ask the Expert: Visual Disorders
Featuring Barry A. Hendin, MD MSAA’s Chief Medical Officer Question: What types of visual disorders may be caused by MS, and are any types of visual issues not typically associated with MS? Answer: Visual signs and symptoms are common in … Continue reading → Source: blog.mymsaa.org
Controling EBV infection
Tweet Host control of persistent Epstein-Barr virus infection. Schmidt A, Alawathurage TM, David FS, Ogawa Y, Frach L, Richter S, Schaefer M, Mathey CM, Henne SK; Japan COVID-19 Task Force; Forstner AJ, Dilthey AT, Pröbstel AK, Boztug K, Nöthen MM, Namkoong H, Okada Y, Beins EC, Ludwig KU. Nature. 2026. doi: 10.1038/s41586-026-10274-4. Online ahead of…
Antibodies to stop EBV infection. Does ProfG get the tool he wants?
Tweet •Transgenic mice were used to make genetically human EBV mAbs against gp350 and gp42 •mAbs potently neutralize EBV infection by blocking receptor-ligand interactions •mAbs prevent EBV infection following EBV challenge in humanized mice We know that there is interest in stopping EBV and there is a view of vaccinating against EBV. However this has…